EU Stakeholders Want More Focus On Availability Of Medicines
Consultation Comments Also Highlight Transparency And Supply Chain Concerns
EU regulators have released their medicines network strategy to 2025 following a consultation that revealed broad support for its aim of ensuring the continued availability of medicines and accelerating innovation, but flagged up a number of areas where respondents wanted more clarity.
